Navigation Links
Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study

malignant brain tumors. Of these, 50% are glioblastomas, the most aggressive type of brain tumor.

Average survival time for newly diagnosed glioblastoma patients receiving the current best available treatment is only 12-15 months.(1) Glioblastomas currently have a near 80% mortality rate within two years, irrespective of the treatment. It is therefore essential that novel treatment options and in particular, targeted therapies such as cilengitide, are investigated.

About the studies
Study 1 (newly diagnosed glioblastoma) is a multicenter, open-label, uncontrolled Phase I/IIa study investigating cilengitide and temozolomide with concomitant radiotherapy, followed by temozolomide and cilengitide maintenance therapy in patients with newly diagnosed glioblastoma. After tumor resection or biopsy, patients were treated with standard temozolomide and radiotherapy. In addition, cilengitide (500mg, iv, twice per week) was started one week before temozolomide and radiotherapy and given throughout for the duration of chemotherapy or until disease progression. The primary endpoint was progression-free survival at six months. The study was conducted at 16 centers in Germany, Switzerland and Belgium.

Study 2 (recurrent glioblastoma) is a multicenter, open-label, randomized, uncontrolled Phase IIa study investigating cilengitide as a single agent in patients with recurrent glioblastoma. Patients were randomized to receive either 500mg or 2000mg of iv cilengitide twice per week until disease progression. The primary endpoint was progression-free survival at six months. The secondary endpoints included response rate, survival, time to disease progression, safety, tolerability and pharmacokinetics. The study was carried out at 15 centers in the US.

About cilengitide
Cilengitide was developed by Merck. It is the first in a new class of targeted anti-cancer therapies in glioblastoma – known as integrin inhibitors – that are thought t
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
2. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
3. Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
4. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
5. Merck Serono Announces Presentation of Phase III Clinical Data on Safinamide in Parkinson’s Disease at the American Academy of Neurology 59th Annual Meeting
6. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
9. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
10. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
11. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control

Post Your Comments:
(Date:11/6/2009)...6 Philips Respironics applauds the...evention (CDC) to raise awareness about an importa...ncy. The CDC,s release of the first-ever governmen...leeplessness is a milestone in quantifying the siz...educator, industry leader and sleep therapy manufa...
(Date:11/6/2009)... N.C., Nov. 6 Chimerix, Inc., a bi... antiviral therapeutics to address life-threatenin...f the company,s lead antiviral compound, CMX001, t...al Health Security Initiative (GHSI). CMX001 is a...r the treatment of smallpox, as well as other seri...
(Date:11/6/2009)...wire-FirstCall/ -- Caraco Pharmaceutical Laborator...c tromethamine ophthalmic solution, 0.5% following...stration (FDA) for Sun Pharma,s Abbreviated New Dr...halmic solution on the first day following patent ...tically equivalent to Acular® Ophthalmic Solu...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2NHIT Processes Over 4 000 Production Transactions Advances Adoption of NHIN Initiative 58809 1NHIT Processes Over 4 000 Production Transactions Advances Adoption of NHIN Initiative 58809 2Cancer Survivors Share The Day I Found Out 28TM 29 58807 1Cancer Survivors Share The Day I Found Out 28TM 29 58807 2You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 1You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 2
...irst Presentation of Full Data Set from the TRIUMP...Treprostinil, SILVER SPRING, Md., May 21 United,...wholly-owned subsidiary,Lung Rx, Inc. today announ...the treatment of pulmonary arterial hypertension (...an Thoracic Society (ATS) meeting in Toronto,Ontar...
...OHANNESBURG, South Africa, May 21 BARC, a global,...ing agreement to support,HIV vaccine trials curren...cine Trials Network (HVTN)., The HVTN vaccine tri...at will advance knowledge and ultimately lead to a...on. The HVTN is supported through a,cooperative ag...
Other Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 2BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 3
(Date:11/8/2009)...,, Higher Costs and Crushing Taxes Nail Nation,...e-USNewswire/ -- In response to U.S. House passage...ss & Entrepreneurship Council (SBE Council) pr...ing statement: ,, "Make no mistake, those voti...creators with higher costs and crushing taxes and ...
(Date:11/8/2009)... Freeze-drying of biophar... Mississauga, Ontario facility. , ...Thomas Wellner, President and CEO of Therapure Bio...aken delivery of a commercial scale pharmaceutical... scale freeze drying (lyophilization) available fo...
(Date:11/8/2009)...,, Nation,s largest network of Hispanic health...h care reform in 2009 ,, WASHINGTON, Nov. 7 /P...f Representatives showed they have heard the voice...ealth Care for America Act. Now the Senate must de... health care reform," said Dr. Jane L. Delgado, Pr...
(Date:11/8/2009)...,, AARP Praises House Passage of Health Care R...ngthen Medicare, improve coverage for all American...- Today, the United States House of Representative...e reform legislation that would strengthen Medicar...companies that prices millions of Americans out of...
(Date:11/7/2009)...,, WASHINGTON , Nov. 7 /PRNewswire-USNewswire...r today in support of H.R. 3962, the Affordable He... the legislation later tonight. Below are the Spe...e all know, is an historic moment for our nation a...eaders of every party and political philosophy -- ...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...dical Small Businesses Will Be Closed Because of M... The American Association for Homecare applauds P...businesses by providing $15 billion in loans to lo...ome medical equipment (HME) sector by rescinding t...
...University and the Georgia Institute of Technology...chers around Atlanta with a dedicated magnetic res...ysteries of the brain and mind. , The Center for ... disabilities, to applied physiology, brain signal...
... 18 Nuvilex, Inc. (OTC Bulletin Board: NVLX), fo...Company,s Spring Break marketing initiatives desig...oducts, InfinitInk and Last Shot Hangover Remedy, ...ms will be combing the beaches, bars and parties o...
... provider ICW celebrates its opening in Canada , ...18 Newt Gingrich, Founder of the Center for Healt...use, along with Frank McKenna, Deputy Chair of TD ...aunch of ICW,s operations in Canada at a luncheon ...
...ws Cesarean deliveries hitting new highs , ...ber of unmarried women who are having babies has r...sarean delivery rates continue to hit new highs, a... from 2006 to 2007. The estimated 1,714,643 babies...
...18 Imaginis.com today announced that it has again... quality from the Health Information Resource Cent...e in providing online patient education informatio...es the best health information Web sites for consu...
Other Medicine News:Health News:American Association for Homecare Applauds President Obama's Plan to Aid Small Businesses 2Health News:American Association for Homecare Applauds President Obama's Plan to Aid Small Businesses 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group 2Health News:Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group 3Health News:Gingrich and McKenna to Speak on Transformation of Healthcare Delivery at ICW Launch 2Health News:Unmarried Childbirths in U.S. Reach Record Levels 2
Protein G, Gold Ribbon - .50 OD per sq. cm.
Protein G, Gold Ribbon - .25 OD per sq. cm.
Protein G, Gold Ribbon - .13 OD per sq. cm.
Naked Gold 80 nm
Medicine Products: